Madrigal's Cholesterol Drug Succeeds in Mid-Stage Trial Post author:Sam Post published:February 7, 2018 Post category:BioPharma MGL-3196 was well-tolerated with primarily mild and some moderate AEs. Source: BioSpace You Might Also Like The Rise and Fall of Cambridge Biotech Startup Gen9 January 24, 2017 Akebia Announces $85M Public Offering March 22, 2018 <b>Martin Shkreli's</b> Complaint Leads to a $100 Million FTC Settlement for This Biotech January 18, 2017
<b>Martin Shkreli's</b> Complaint Leads to a $100 Million FTC Settlement for This Biotech January 18, 2017
